Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma

A differentiation antigen commonly expressed on melanoma cells, gp100 is the target of infiltrating T cells. We conducted a phase I randomized cross-over trial of melanoma patients with either xenogeneic (mouse) or human gp100 plasmid DNA injected intramuscularly at three dosages (100, 500 or 1,500 ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yuan, Jianda, Ku, Geoffrey Y., Gallardo, Humilidad F., Orlandi, Francesca, Manukian, Gregor, Rasalan, Teresa S., Xu, Yinyan, Li, Hao, Vyas, Shachi, Mu, Zhenyu, Chapman, Paul B., Krown, Susan E., Panageas, Katherine, Terzulli, Stephanie L., Old, Lloyd J., Houghton, Alan N., Wolchok, Jedd D.
Formato: Artigo
Idioma:Inglês
Publicado em: Academy of Cancer Immunology 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2888533/
https://ncbi.nlm.nih.gov/pubmed/19496531
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados